Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 22;12(1):32-41.
doi: 10.1055/s-0041-1731020. eCollection 2023 Mar.

Cohort of Phenotype, Genotype, and Outcome of SCN Developmental and Epileptic Encephalopathies from Southern Part of India

Vykuntaraju K Gowda  1 , Manojna Battina  1 , Hemadri Vegda  1 , Varunvenkat M Srinivasan  1 , Surendra K Chikara  2 , Adrija Mishra  2 , Sanjay K Shivappa  3 , Naveen Benakappa  3
Affiliations

Cohort of Phenotype, Genotype, and Outcome of SCN Developmental and Epileptic Encephalopathies from Southern Part of India

Vykuntaraju K Gowda et al. J Pediatr Genet. .

Abstract

The SCN encephalopathies are one of the rare early childhood intractable epileptic encephalopathies associated with pleomorphic seizures, cognitive decline, motor, and behavioral abnormalities that begin in early infancy. There is a dearth of data on phenotype and genotype of SCN encephalopathies from the Indian subcontinent, hence we are reporting clinical and molecular profile and outcome of SCN developmental and epileptic encephalopathies. This is a retrospective chart review of SCN developmental and epileptic encephalopathies in a tertiary care center, Bangalore, India between January 2015 and March 2020. All children with clinical features of SCN developmental and epileptic encephalopathies and confirmed with pathogenic variants were included. A total of 50 cases of SCN developmental and epileptic encephalopathies were analyzed, 31 of them were male and the mean age of presentation was 7.8 months. Precipitating factors for the first episode of seizure were fever and vaccination accounting for 33 and 8 children, respectively. Forty (80%) children had prolonged seizures and 15 (30%) had epileptic spasms. All children had a normal birth history and normal development before the onset of seizures, which was followed by developmental delay and regression. Thirty (60%) children had behavioral difficulties, notable hyperactivity, and autistic features. Neuroimaging and the initial electroencephalogram (EEG) were normal in all patients. The mean age of abnormal EEG was 14 months. The various subtypes of SCN variants were SCN1A in 31 children followed by SCN2A and SCN9A in eight children each and SCN1B in three children. Frameshift and nonsense mutations were associated with more severe phenotype and poor outcome compared with missense mutations. Thirty-four patients partially responded to treatment and the rest were refractory. The results of genetic testing were used to guide treatment; sodium channel blocking antiepileptic drugs were discontinued in 15 patients and sodium channel blocking agents were started in 3 patients with partial response. Three out of four children on stiripentol had a partial response. The SCN developmental and epileptic encephalopathies can present with epileptic spasms in addition to other types of seizures. Epileptic spasms are more common in nonsense and frameshift mutations. The outcome is poor in children with epileptic spasms compared with those without epileptic spasms. Genetic testing helps to select antiepileptic drugs that lead to seizure reduction.

Keywords: Dravet syndrome; SCN developmental and epileptic encephalopathies; SCN mutation; epileptic spasms.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

Figures

Fig. 1
Fig. 1
Showing various subtypes of SCN developmental and epileptic encephalopathies.
Fig. 2
Fig. 2
Showing type of mutations in SCN developmental and epileptic encephalopathies.
Fig. 3
Fig. 3
Showing response to antiepileptic drugs in SCN developmental and epileptic encephalopathies.
Fig. 4
Fig. 4
Showing epileptic spasms in various subtypes of SCN mutations in SCN developmental and epileptic encephalopathies.
Fig. 5
Fig. 5
Showing epileptic spasms in various types of SCN mutations in SCN developmental and epileptic encephalopathies.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Identification of five novel SCN1A variants.
    Zeng B, Zhang H, Lu Q, Fu Q, Yan Y, Lu W, Ma P, Feng C, Qin J, Luo L, Yang B, Zou Y, Liu Y. Zeng B, et al. Front Behav Neurosci. 2023 Nov 8;17:1272748. doi: 10.3389/fnbeh.2023.1272748. eCollection 2023. Front Behav Neurosci. 2023. PMID: 38025388 Free PMC article.

References

    1. Scheffer I E, Nabbout R. SCN1A -related phenotypes: Epilepsy and beyond . Epilepsia. 2019;60 03:S17–S24. - PubMed
    1. Hattori J, Ouchida M, Ono J. A screening test for the prediction of Dravet syndrome before one year of age. Epilepsia. 2008;49(04):626–633. - PubMed
    1. Fujiwara T, Sugawara T, Mazaki-Miyazaki E. Mutations of sodium channel alpha subunit type 1 ( SCN1A ) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures Brain 2003126(Pt 3):531–546. - PubMed
    1. Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O. Severe myoclonic epilepsy in infancy: Dravet syndrome. Adv Neurol. 2005;95:71–102. - PubMed
    1. Brunklaus A, Ellis R, Reavey E, Forbes G H, Zuberi S M. Prognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome Brain 2012135(Pt 8):2329–2336. - PubMed